Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG oncology/gynecologic oncology group study.

Elizabeth R Burton,Mark F Brady,Howard D Homesley,Peter G Rose,Toshiaki Nakamura,Joshua P Kesterson,Jacob Rotmensch,J Tate Thigpen,Linda Van Le

Gynecologic Oncology（2016）

Cited 19|Views23
No score
Abstract
•Paclitaxel has activity in recurrent, malignant stromal tumor of the ovary.•There was a complete response in 3.2% and partial response in 25.8% of women.•Inhibin is not a reliable tumor marker.
More
Translated text
Key words
Stromal tumor of ovary,Paclitaxel
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined